Europe
Moderna is working with international regulators to accelerate approval of the company’s COVID-19 vaccine candidate, mRNA-1273.
Biopharma and life sciences companies bolster their leadership teams with these Movers & Shakers.
The pharma giant is currently the only manufacturer of the bladder cancer treatment for the U.S. and Europe.
Several biopharmaceutical companies have made headway as of late in the race to develop a vaccine for COVID-19, which is responsible for the current global pandemic.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Find out which life sciences companies are raking in the cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Relief Therapeutics and NeuroRx released results on Tuesday from their open-label prospective study looking into RLF-100 (aviptadil) as a potential treatment for COVID-19 and respiratory failure.
To date, all the major clinical trials of vaccines against COVID-19 have been in adults.
Dyno will be responsible for the design of the novel AAV capsids that are expected to have improved functional properties for gene therapy. Roche and its subsidiary Spark Therapeutics will take the capsids and conduct preclinical studies with hopes of taking them into the clinic, and eventually to commercialization.
PRESS RELEASES